1. Home
  2. RGEN vs PNFP Comparison

RGEN vs PNFP Comparison

Compare RGEN & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • PNFP
  • Stock Information
  • Founded
  • RGEN 1981
  • PNFP 2000
  • Country
  • RGEN United States
  • PNFP United States
  • Employees
  • RGEN N/A
  • PNFP N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • PNFP Major Banks
  • Sector
  • RGEN Health Care
  • PNFP Finance
  • Exchange
  • RGEN Nasdaq
  • PNFP Nasdaq
  • Market Cap
  • RGEN 8.0B
  • PNFP 9.1B
  • IPO Year
  • RGEN N/A
  • PNFP N/A
  • Fundamental
  • Price
  • RGEN $121.74
  • PNFP $91.56
  • Analyst Decision
  • RGEN Buy
  • PNFP Buy
  • Analyst Count
  • RGEN 12
  • PNFP 12
  • Target Price
  • RGEN $168.40
  • PNFP $129.92
  • AVG Volume (30 Days)
  • RGEN 759.3K
  • PNFP 1.2M
  • Earning Date
  • RGEN 07-29-2025
  • PNFP 07-15-2025
  • Dividend Yield
  • RGEN N/A
  • PNFP 0.92%
  • EPS Growth
  • RGEN N/A
  • PNFP 48.26
  • EPS
  • RGEN N/A
  • PNFP 7.51
  • Revenue
  • RGEN $650,429,000.00
  • PNFP $1,812,787,000.00
  • Revenue This Year
  • RGEN $14.06
  • PNFP $27.34
  • Revenue Next Year
  • RGEN $14.33
  • PNFP $11.66
  • P/E Ratio
  • RGEN N/A
  • PNFP $13.87
  • Revenue Growth
  • RGEN 4.88
  • PNFP 21.56
  • 52 Week Low
  • RGEN $102.97
  • PNFP $81.57
  • 52 Week High
  • RGEN $182.52
  • PNFP $131.91
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 48.77
  • PNFP 23.42
  • Support Level
  • RGEN $116.30
  • PNFP $111.77
  • Resistance Level
  • RGEN $125.00
  • PNFP $119.85
  • Average True Range (ATR)
  • RGEN 5.00
  • PNFP 3.80
  • MACD
  • RGEN -0.32
  • PNFP -2.70
  • Stochastic Oscillator
  • RGEN 44.03
  • PNFP 16.13

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

Share on Social Networks: